Company Event • 23 Feb 2021 14:30 • Latest
No more events
𝛼SK or SearchENTITY
Junshi Biosciences (1877 HK)
Junshi Biosciences (1877 HK)
292
Analysis
Health Care • China
Junshi Biosciences is an innovation-driven biopharmaceutical company focused on the discovery, development, clinical research, and commercialization of innovative therapeutics. Its key products, including toripalimab injection, Etesevimab, and adalimumab injection, are used to treat malignant tumors, autoimmune diseases, chronic metabolic diseases, nervous system diseases, and infectious diseases. The company was founded in December 2012 and is headquartered in Shanghai, China.
morex